Uroplasty's FDA-approved nerve stimulation device for overactive bladder now available

By Lisa Kerner

Charlotte, N.C., July 5 - Uroplasty, Inc. said its next-generation Urgent PC Neuromodulation System is now available for sale in the United States.

The non-surgical nerve stimulation device for the treatment of overactive bladder symptoms received Food and Drug Administration 510(k) clearance on Monday.

An estimated 34 million Americans suffer from overactive bladder symptoms of urinary urgency, urinary frequency or urge incontinence, according to a company news release.

Uroplasty is a medical device company based in Minnetonka, Minn.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.